Apyx Medical Co. (NASDAQ:APYX) Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP grew its holdings in Apyx Medical Co. (NASDAQ:APYX) by 2.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 378,559 shares of the company’s stock after buying an additional 10,656 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Apyx Medical were worth $2,726,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. raised its position in shares of Apyx Medical by 4.3% in the fourth quarter. BlackRock Inc. now owns 2,328,764 shares of the company’s stock valued at $16,767,000 after buying an additional 96,536 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Apyx Medical by 5.7% in the fourth quarter. JPMorgan Chase & Co. now owns 641,380 shares of the company’s stock valued at $4,618,000 after buying an additional 34,817 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its position in shares of Apyx Medical by 2.8% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 264,555 shares of the company’s stock valued at $1,905,000 after buying an additional 7,245 shares during the last quarter. Millrace Asset Group Inc. raised its position in shares of Apyx Medical by 208.7% in the fourth quarter. Millrace Asset Group Inc. now owns 166,536 shares of the company’s stock valued at $1,199,000 after buying an additional 112,594 shares during the last quarter. Finally, Wells Fargo & Company MN grew its holdings in shares of Apyx Medical by 9.1% in the fourth quarter. Wells Fargo & Company MN now owns 100,199 shares of the company’s stock valued at $721,000 after purchasing an additional 8,379 shares during the period. Institutional investors and hedge funds own 55.29% of the company’s stock.

Shares of APYX stock opened at $10.01 on Friday. The stock has a market capitalization of $343.52 million, a price-to-earnings ratio of -23.28 and a beta of 0.75. The stock’s 50-day moving average is $9.77. Apyx Medical Co. has a 1-year low of $4.35 and a 1-year high of $12.01.

Apyx Medical (NASDAQ:APYX) last announced its earnings results on Wednesday, May 12th. The company reported ($0.14) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.15) by $0.01. Apyx Medical had a negative net margin of 47.35% and a negative return on equity of 24.39%. Sell-side analysts expect that Apyx Medical Co. will post -0.56 EPS for the current fiscal year.

A number of brokerages recently issued reports on APYX. Zacks Investment Research raised shares of Apyx Medical from a “sell” rating to a “hold” rating in a report on Monday, May 17th. Colliers Securities reissued a “buy” rating on shares of Apyx Medical in a report on Tuesday, March 30th.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue.

Recommended Story: What is the Bid-Ask Spread?

Want to see what other hedge funds are holding APYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apyx Medical Co. (NASDAQ:APYX).

Institutional Ownership by Quarter for Apyx Medical (NASDAQ:APYX)

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.